LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 45

Search options

  1. Article ; Online: Antitumor Activity of Rutaecarpine in Human Colorectal Cancer Cells by Suppression of Wnt/β-Catenin Signaling.

    Byun, Woong Sub / Bae, Eun Seo / Kim, Won Kyung / Lee, Sang Kook

    Journal of natural products

    2022  Volume 85, Issue 5, Page(s) 1407–1418

    Abstract: Alkaloids derived from natural products have been traditionally used to treat various diseases, including cancers. Rutaecarpine ( ...

    Abstract Alkaloids derived from natural products have been traditionally used to treat various diseases, including cancers. Rutaecarpine (
    MeSH term(s) Animals ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; Colorectal Neoplasms/drug therapy ; Humans ; Indole Alkaloids ; Mice ; Quinazolines ; Wnt Signaling Pathway ; beta Catenin
    Chemical Substances Indole Alkaloids ; Quinazolines ; beta Catenin ; rutecarpine (8XZV289PRY)
    Language English
    Publishing date 2022-05-11
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 304325-3
    ISSN 1520-6025 ; 0163-3864
    ISSN (online) 1520-6025
    ISSN 0163-3864
    DOI 10.1021/acs.jnatprod.2c00224
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Antitumor Activity of Rutaecarpine in Human Colorectal Cancer Cells by Suppression of Wnt/β-Catenin Signaling

    Byun, Woong Sub / Bae, Eun Seo / Kim, Won Kyung / Lee, Sang Kook

    Journal of natural products. 2022 May 11, v. 85, no. 5

    2022  

    Abstract: Alkaloids derived from natural products have been traditionally used to treat various diseases, including cancers. Rutaecarpine (1), a β-carboline-type alkaloid obtained from Evodia rutaecarpa, has been previously reported as an anti-inflammatory agent. ... ...

    Abstract Alkaloids derived from natural products have been traditionally used to treat various diseases, including cancers. Rutaecarpine (1), a β-carboline-type alkaloid obtained from Evodia rutaecarpa, has been previously reported as an anti-inflammatory agent. Nonetheless, its anticancer activity and the underlying molecular mechanisms remain to be explored. In the procurement of Wnt/β-catenin inhibitors from natural alkaloids, 1 was found to exhibit activity against the Wnt/β-catenin-response reporter gene. Since the abnormal activation of Wnt/β-catenin signaling is highly involved in colon carcinogenesis, the antitumor activity and molecular mechanisms of 1 were investigated in colorectal cancer (CRC) cells. The antiproliferative activity of 1 was associated with the suppression of the Wnt/β-catenin-mediated signaling pathway and its target gene expression in human CRC cells. 1 also induced G₀/G₁ cell cycle arrest and apoptotic cell death, and the antimigration and anti-invasion potential of 1 was confirmed through epithelial–mesenchymal transition biomarker inhibition by the regulation of Wnt signaling. The antitumor activity of 1 was supported in an Ls174T-implanted xenograft mouse model via Wnt target gene regulation. Overall, these findings suggest that targeting the Wnt/β-catenin signaling pathway by 1 is a promising therapeutic option for the treatment of human CRC harboring β-catenin mutation.
    Keywords Euodia ; alkaloids ; anti-inflammatory agents ; antineoplastic activity ; apoptosis ; biomarkers ; carcinogenesis ; cell cycle checkpoints ; colon ; colorectal neoplasms ; gene expression ; humans ; mice ; mutation ; reporter genes ; xenotransplantation
    Language English
    Dates of publication 2022-0511
    Size p. 1407-1418.
    Publishing place American Chemical Society and American Society of Pharmacognosy
    Document type Article
    ZDB-ID 304325-3
    ISSN 1520-6025 ; 0163-3864
    ISSN (online) 1520-6025
    ISSN 0163-3864
    DOI 10.1021/acs.jnatprod.2c00224
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Design, Synthesis, and Biological Activity of Marinacarboline Analogues as STAT3 Pathway Inhibitors for Docetaxel-Resistant Triple-Negative Breast Cancer.

    Byun, Woong Sub / Lim, Hyewon / Hong, Junhwa / Bae, Eun Seo / Lee, Seok Beom / Kim, Younggwan / Lee, Jeeyeon / Lee, Sang Kook / Hong, Suckchang

    Journal of medicinal chemistry

    2023  Volume 66, Issue 4, Page(s) 3106–3133

    Abstract: Metastatic triple-negative breast cancer (mTNBC) is a fatal type of breast cancer (BC), and signal transducer and activator of transcription 3 (STAT3) has emerged as an effective target for mTNBC. In the present study, ... ...

    Abstract Metastatic triple-negative breast cancer (mTNBC) is a fatal type of breast cancer (BC), and signal transducer and activator of transcription 3 (STAT3) has emerged as an effective target for mTNBC. In the present study, compound
    MeSH term(s) Humans ; Animals ; Mice ; Docetaxel/therapeutic use ; Triple Negative Breast Neoplasms/drug therapy ; STAT3 Transcription Factor/metabolism ; Apoptosis ; Xenograft Model Antitumor Assays ; Cell Line, Tumor ; Cell Proliferation ; Antineoplastic Agents/pharmacology
    Chemical Substances Docetaxel (15H5577CQD) ; STAT3 Transcription Factor ; Antineoplastic Agents ; STAT3 protein, human
    Language English
    Publishing date 2023-02-14
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.2c01115
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Synthesis and biological evaluation of atropisomeric tetrahydroisoquinolines overcoming docetaxel resistance in triple-negative human breast cancer cells.

    Song, Jayoung / Kim, Ahreum / Hong, Intaek / Kim, Sangji / Byun, Woong Sub / Lee, Hyun Soo / Kim, Hyung Sik / Lee, Sang Kook / Kwon, Yongseok

    Bioorganic chemistry

    2023  Volume 137, Page(s) 106573

    Abstract: Herein, atropisomeric 8-aryltetrahydroisoquinolines have been synthesized and biologically evaluated. Based on our structure-activity relationship study, a highly bioactive racemic compound has been produced, and it exhibited high antiproliferative ... ...

    Abstract Herein, atropisomeric 8-aryltetrahydroisoquinolines have been synthesized and biologically evaluated. Based on our structure-activity relationship study, a highly bioactive racemic compound has been produced, and it exhibited high antiproliferative activities against various cancer cell lines, including docetaxel-resistant breast cancer cell lines. Each enantiomer can be synthesized in an enantioselective manner by employing the chiral phosphoric acid-catalyzed atroposelective Pictet-Spengler cyclization. An axially (R)-configured enantiomer showed a higher biological activity compared with the axially (S)-configured enantiomer. Further biological studies suggested that the (R)-enantiomer overcomes docetaxel resistance via the downregulation of signal transducer and activator of transcription 3 activation and consequently induces cellular apoptosis in docetaxel-resistant triple-negative breast cancer cell lines.
    MeSH term(s) Humans ; Docetaxel/pharmacology ; Tetrahydroisoquinolines ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/metabolism ; Apoptosis ; Cell Line, Tumor
    Chemical Substances Docetaxel (15H5577CQD) ; Tetrahydroisoquinolines
    Language English
    Publishing date 2023-04-29
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120080-x
    ISSN 1090-2120 ; 0045-2068
    ISSN (online) 1090-2120
    ISSN 0045-2068
    DOI 10.1016/j.bioorg.2023.106573
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Inhibition of DOT1L by Half-Selenopsammaplin A Analogs Suppresses Tumor Growth and EMT-Mediated Metastasis in Triple-Negative Breast Cancer.

    Byun, Woong Sub / Lee, Gyu Ho / Park, Hyeung-Geun / Lee, Sang Kook

    Pharmaceuticals (Basel, Switzerland)

    2020  Volume 14, Issue 1

    Abstract: Due to a lack of hormone receptors, current treatment strategies for triple-negative breast cancer (TNBC) are limited with frequent disease recurrence and metastasis. Recent findings have suggested that aberrant methylation of histone H3 lysine 79 ... ...

    Abstract Due to a lack of hormone receptors, current treatment strategies for triple-negative breast cancer (TNBC) are limited with frequent disease recurrence and metastasis. Recent findings have suggested that aberrant methylation of histone H3 lysine 79 residue (H3K79me) by the histone methyltransferase disruptor of telomeric silencing 1-like (DOT1L) is a potential therapeutic target for TNBC clinical management. Therefore, we developed DOT1L inhibitors as potential antitumor agents against TNBC cells. We reveal that a synthetic half-selenopsammaplin A analog 9l (subsequently known as 9l) exhibited inhibitory activity against DOT1L-mediated H3K79 methylation, and showed antitumor activity in TNBC cells. The analog 9l also significantly inhibited TNBC invasion and migration via the modulation of epithelial-mesenchymal transition (EMT) markers, including N-cadherin and vimentin downregulation and E-cadherin upregulation. In an MDA-MB-231/Luc-implanted orthotopic mouse metastasis model, treatment with 9l effectively inhibited tumor growth and lung metastasis via DOT1L regulatory activity and EMT processes. Taken together, these findings highlight the potential of 9l as a novel therapeutic candidate for treating metastatic TNBC via DOT1L modulation.
    Language English
    Publishing date 2020-12-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2193542-7
    ISSN 1424-8247
    ISSN 1424-8247
    DOI 10.3390/ph14010018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Antitumor Activity of Asperphenin B by Induction of Apoptosis and Regulation of Glyceraldehyde-3-phosphate Dehydrogenase in Human Colorectal Cancer Cells

    Byun, Woong Sub / Bae, Eun Seo / Park, Sung Chul / Kim, Won Kyung / Shin, Jongheon / Lee, Sang Kook

    Journal of natural products. 2021 Jan. 05, v. 84, no. 3

    2021  

    Abstract: Colorectal cancer (CRC) is a common and intractable malignancy with a high mortality risk. Conventional chemotherapeutics are effective for patients with early stage CRC, but the majority of deaths of CRC patients are linked to acquired drug resistance ... ...

    Abstract Colorectal cancer (CRC) is a common and intractable malignancy with a high mortality risk. Conventional chemotherapeutics are effective for patients with early stage CRC, but the majority of deaths of CRC patients are linked to acquired drug resistance or metastasis occurrence. Asperphenin B (1), a lipopeptidyl benzophenone isolated from a marine-derived Aspergillus sp. fungus, reportedly possesses antiproliferative activity against cancer cells. However, its antitumor activity and the underlying molecular mechanisms remain unexplored. In this study, 1 induced G₂/M phase cell cycle arrest and subsequent apoptotic cell death and inhibited tumor growth in a xenograft model. The 1-induced G₂/M phase arrest was associated with the regulation of checkpoint proteins, including Chk1/2 and Cdc25c. The 1-induced apoptosis was correlated with an upregulation of p53 and cleaved caspases and a downregulation of survivin. Further experiments revealed that 1-mediated suppression of migration and invasion of metastatic HCT116 cells was partially associated with the downregulation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression. The antimetastatic potential of 1 was also confirmed by E-cadherin upregulation and N-cadherin and Snail downregulation, which were in turn associated with the GAPDH regulation. These findings highlight the potential use of 1 as a novel candidate for treating metastatic CRC with the modulation of GAPDH function.
    Keywords Aspergillus ; antineoplastic activity ; apoptosis ; benzophenones ; cadherins ; caspases ; cell cycle checkpoints ; colorectal neoplasms ; drug resistance ; drug therapy ; fungi ; glyceraldehyde-3-phosphate dehydrogenase ; humans ; metastasis ; models ; mortality ; pro-apoptotic proteins ; risk ; xenotransplantation
    Language English
    Dates of publication 2021-0105
    Size p. 683-693.
    Publishing place American Chemical Society and American Society of Pharmacognosy
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 304325-3
    ISSN 1520-6025 ; 0163-3864
    ISSN (online) 1520-6025
    ISSN 0163-3864
    DOI 10.1021/acs.jnatprod.0c01155
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells.

    Bae, Eun Seo / Byun, Woong Sub / Ock, Chae Won / Kim, Won Kyung / Park, Hyen Joo / Lee, Sang Kook

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

    2022  Volume 157, Page(s) 114039

    Abstract: Although gemcitabine-based chemotherapy is common and effective for pancreatic cancer (PC), acquired drug resistance is one of the major reasons for treatment failure. Therefore, a novel therapeutic approach for gemcitabine-resistant PC is required. ... ...

    Abstract Although gemcitabine-based chemotherapy is common and effective for pancreatic cancer (PC), acquired drug resistance is one of the major reasons for treatment failure. Therefore, a novel therapeutic approach for gemcitabine-resistant PC is required. Nuclear factor erythroid 2-related factor 2 (Nrf2) is an oxidative stress-responsive transcription factor regulating antioxidant responses and plays a crucial role in chemoresistance. In the present study, the antitumor activity of periplocin, a natural cardiac glycoside, was evaluated in an established gemcitabine-resistant PC cell line (PANC-GR). Nrf2 was overexpressed in gemcitabine-resistant cells, and Nrf2 knockdown recovered gemcitabine sensitivity in PANC-GR cells. The antiproliferative activity of periplocin was highly associated with Nrf2 downregulation and Nrf2-mediated signaling pathways in PANC-GR cells. Periplocin also increased reactive oxygen species production inducing G
    MeSH term(s) Humans ; Mice ; Animals ; Gemcitabine ; Deoxycytidine/pharmacology ; Deoxycytidine/therapeutic use ; Drug Resistance, Neoplasm ; Cell Line, Tumor ; Pancreatic Neoplasms/pathology ; Signal Transduction ; Apoptosis ; Xenograft Model Antitumor Assays ; Pancreatic Neoplasms
    Chemical Substances Gemcitabine ; Deoxycytidine (0W860991D6)
    Language English
    Publishing date 2022-11-21
    Publishing country France
    Document type Journal Article
    ZDB-ID 392415-4
    ISSN 1950-6007 ; 0753-3322 ; 0300-0893
    ISSN (online) 1950-6007
    ISSN 0753-3322 ; 0300-0893
    DOI 10.1016/j.biopha.2022.114039
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library.

    Razumkov, Hlib / Jiang, Zixuan / Baek, Kheewoong / You, Inchul / Geng, Qixiang / Donovan, Katherine A / Tang, Michelle T / Metivier, Rebecca J / Mageed, Nada / Seo, Pooreum / Li, Zhengnian / Byun, Woong Sub / Hinshaw, Stephen M / Sarott, Roman C / Fischer, Eric S / Gray, Nathanael S

    bioRxiv : the preprint server for biology

    2024  

    Abstract: Small molecules promoting protein-protein interactions produce a range of therapeutic outcomes. Molecular glue degraders exemplify this concept due to their compact drug-like structures and ability to engage targets without reliance on existing cognate ... ...

    Abstract Small molecules promoting protein-protein interactions produce a range of therapeutic outcomes. Molecular glue degraders exemplify this concept due to their compact drug-like structures and ability to engage targets without reliance on existing cognate ligands. While Cereblon molecular glue degraders containing glutarimide scaffolds have been approved for treatment of multiple myeloma and acute myeloid leukemia, the design of new therapeutically relevant monovalent degraders remains challenging. We report here an approach to glutarimide-containing molecular glue synthesis using multicomponent reactions as a central modular core-forming step. Screening the resulting library identified HRZ-01 derivatives that target casein kinase 1 alpha (CK1α) and Wee-like protein kinase (WEE1). Further medicinal chemistry efforts led to identification of selective monovalent WEE1 degraders that provide a potential starting point for the eventual development of a selective chemical degrader probe. The structure of the hit WEE1 degrader complex with CRBN-DDB1 and WEE1 provides a model of the protein-protein interface and a rationale for the observed kinase selectivity. Our findings suggest that modular synthetic routes combined with in-depth structural characterization give access to selective molecular glue degraders and expansion of the CRBN-degradable proteome.
    Language English
    Publishing date 2024-05-05
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2024.05.04.592550
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Conference proceedings: Antitumour activity of a natural cardiac glycoside, periplocin, by regulating Nrf2-mediated signalling pathway in gemcitabine-resistant pancreatic cancer cells

    Lee, Sang Kook / Bae, Eun Seo / Byun, Woong Sub / Ock, Chae Won / Kim, Won Kyung / Park, Hyen Joo

    Planta Medica

    2023  Volume 89, Issue 14

    Event/congress 71st International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA), Trinity College Dublin Ireland, 2023-07-02
    Language English
    Publishing date 2023-11-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article ; Conference proceedings
    ZDB-ID 123545-x
    ISSN 1439-0221 ; 0032-0943
    ISSN (online) 1439-0221
    ISSN 0032-0943
    DOI 10.1055/s-0043-1774237
    Database Thieme publisher's database

    More links

    Kategorien

  10. Article ; Online: Proteomics-Based Discovery of First-in-Class Chemical Probes for Programmed Cell Death Protein 2 (PDCD2).

    Ji, Wenzhi / Byun, Woong Sub / Lu, Wenchao / Zhu, Xijun / Donovan, Katherine A / Dwyer, Brendan G / Che, Jianwei / Yuan, Linjie / Abulaiti, Xianmixinuer / Corsello, Steven M / Fischer, Eric S / Zhang, Tinghu / Gray, Nathanael S

    Angewandte Chemie (International ed. in English)

    2023  Volume 62, Issue 43, Page(s) e202308292

    Abstract: Chemical probes are essential tools for understanding biological systems and for credentialing potential biomedical targets. Programmed cell death 2 (PDCD2) is a member of the B-cell lymphoma 2 (Bcl-2) family of proteins, which are critical regulators of ...

    Abstract Chemical probes are essential tools for understanding biological systems and for credentialing potential biomedical targets. Programmed cell death 2 (PDCD2) is a member of the B-cell lymphoma 2 (Bcl-2) family of proteins, which are critical regulators of apoptosis. Here we report the discovery and characterization of 10 e, a first-in-class small molecule degrader of PDCD2. We discovered this PDCD2 degrader by serendipity using a chemical proteomics approach, in contrast to the conventional approach for making bivalent degraders starting from a known binding ligand targeting the protein of interest. Using 10 e as a pharmacological probe, we demonstrate that PDCD2 functions as a critical regulator of cell growth by modulating the progression of the cell cycle in T lymphoblasts. Our work provides a useful pharmacological probe for investigating PDCD2 function and highlights the use of chemical proteomics to discover selective small molecule degraders of unanticipated targets.
    MeSH term(s) Humans ; Apoptosis Regulatory Proteins/metabolism ; Proteomics ; Apoptosis ; Lymphoma, B-Cell ; Cell Proliferation
    Chemical Substances Apoptosis Regulatory Proteins ; PDCD2 protein, human
    Language English
    Publishing date 2023-09-15
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.202308292
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top